The TH17 pathway as a therapeutic target in experimental arthritis. Interfering with the induction and effector phases: not a problem et al.

Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.

Grevers, L.C.
Lent, P.L.E.M. van
Koenders, M.I.
Walgreen, B.
Sloetjes, A.W.
Nimmerjahn, F.
Verbeek, J.S.
Berg, W.B. van den

January 2009

Contains fulltext : 80444.pdf (publisher's version ) (Closed access)OBJECTIVE: Pre...

Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice.

Koenders, M.I.
Devesa, I.
Marijnissen, R.J.
Abdollahi-Roodsaz, S.
Boots, A.M.H.
Walgreen, B.
Padova, F.E. Di
Nicklin, M.J.
Joosten, L.A.B.
Berg, W.B. van den

January 2008

Contains fulltext : 69671.pdf (publisher's version ) (Closed access)OBJECTIVE: Int...

T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.

Joosten, L.A.B.
Abdollahi-Roodsaz, S.
Heuvelmans-Jacobs, M.
Helsen, M.M.A.
Bersselaar, L.A.M. van den
Oppers-Walgreen, B.
Koenders, M.I.
Berg, W.B. van den

January 2008

Contains fulltext : 70898.pdf (publisher's version ) (Closed access)OBJECTIVE: The...

Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis.

Koenders, M.I.
Joosten, L.A.B.
Berg, W.B. van den

January 2006

Contains fulltext : 49248.pdf (publisher's version ) (Closed access)Rheumatoid art...

IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis?

Lubberts, Erik

February 2008

textabstractInterleukin-17A (IL-17A) contributes to the pathogenesis of arthritis. Data from experim...

The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models.

Lubberts, E.
Koenders, M.I.
Berg, W.B. van den

January 2005

Contains fulltext : 48096.pdf (publisher's version ) (Open Access)Interleukin-17 (...

Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.

Koenders, M.I.
Lubberts, E.
Oppers-Walgreen, B.
Bersselaar, L.A.M. van den
Helsen, M.M.A.
Padova, F.E. Di
Boots, A.M.H.
Gram, H.
Joosten, L.A.B.
Berg, W.B. van den

January 2005

Contains fulltext : 47662.pdf (publisher's version ) (Closed access)Rheumatoid art...

Neutrophils are essential as a source of IL-17 in the effector phase of arthritis. PLoS One. 2013; 8:e62231. [PubMed: 23671588

Masaki Katayama
Koichiro Ohmura
Naoichiro Yukawa
Chikashi Terao
Motomu Hashimoto
Hajime Yoshifuji
Daisuke Kawabata
Takao Fujii
Yoichiro Iwakura
Tsuneyo Mimori

August 2016

Objective: Th17 has been shown to have a pivotal role in the development of arthritis. However, the ...

Incomplete response of inflammatory arthritis to TNF alpha blockade is associated with the Th17 pathway

Alzabin, S
Abraham, SM
Taher, TE
Palfreeman, A
Hull, D
McNamee, K
Jawad, A
Pathan, E
Kinderlerer, A
Taylor, PC
Williams, R
Mageed, R

October 2012

Objectives: To establish if changes in Th1/Th17 cell populations previously reported in experimental...

Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway.

Alzabin, S
Abraham, SM
Taher, TE
Palfreeman, A
Hull, D
McNamee, K
Jawad, A
Pathan, E
Kinderlerer, A
Taylor, PC
Williams, R
Mageed, R

October 2012

OBJECTIVES: To establish if changes in Th1/Th17 cell populations previously reported in experimental...

Higher efficacy of anti-IL-6/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis

Roeleveld, D.M.
Marijnissen, R.J.
Walgreen, B.
Helsen, M.M.A.
Bersselaar, L.A.M. van den
Loo, F.A. van de
Lent, P.L.E.M. van
Kraan, P.M. van der
Berg, W.B. van den
Koenders, M.I.

January 2017

Contains fulltext : 173198.pdf (publisher's version ) (Open Access)Th17 cells and ...

Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression.

Toh, M.L.
Gonzales, G.
Koenders, M.I.
Tournadre, A.
Boyle, D.
Lubberts, E.
Zhou, Y.
Firestein, G.S.
Berg, W.B. van den
Miossec, P.

January 2010

Contains fulltext : 89354.pdf (publisher's version ) (Open Access)BACKGROUND: The ...

Neutrophils are essential as a source of IL-17 in the effector phase of arthritis.

Masaki Katayama
Koichiro Ohmura
Naoichiro Yukawa
Chikashi Terao
Motomu Hashimoto
Hajime Yoshifuji
Daisuke Kawabata
Takao Fujii
Yoichiro Iwakura
Tsuneyo Mimori

OBJECTIVE: Th17 has been shown to have a pivotal role in the development of arthritis. However, the ...

Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.

Koenders, M.I.
Lubberts, E.
Oppers-Walgreen, B.
Bersselaar, L.A.M. van den
Helsen, M.M.A.
Kolls, J.
Joosten, L.A.B.
Berg, W.B. van den

January 2005

Contains fulltext : 48047.pdf (publisher's version ) (Closed access)OBJECTIVE: To ...

IL-17 as a future therapeutic target for rheumatoid arthritis.

Berg, W.B. van den
Miossec, P.

January 2009

Item does not contain fulltextThe discovery of interleukin (IL)-17 and its major cell source, the ty...

Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.

Grevers, L.C.
Lent, P.L.E.M. van
Koenders, M.I.
Walgreen, B.
Sloetjes, A.W.
Nimmerjahn, F.
Verbeek, J.S.
Berg, W.B. van den

January 2009

Contains fulltext : 80444.pdf (publisher's version ) (Closed access)OBJECTIVE: Pre...

Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice.

Koenders, M.I.
Devesa, I.
Marijnissen, R.J.
Abdollahi-Roodsaz, S.
Boots, A.M.H.
Walgreen, B.
Padova, F.E. Di
Nicklin, M.J.
Joosten, L.A.B.
Berg, W.B. van den

January 2008

Contains fulltext : 69671.pdf (publisher's version ) (Closed access)OBJECTIVE: Int...

T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.

Joosten, L.A.B.
Abdollahi-Roodsaz, S.
Heuvelmans-Jacobs, M.
Helsen, M.M.A.
Bersselaar, L.A.M. van den
Oppers-Walgreen, B.
Koenders, M.I.
Berg, W.B. van den

January 2008

Contains fulltext : 70898.pdf (publisher's version ) (Closed access)OBJECTIVE: The...

Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis.

Koenders, M.I.
Joosten, L.A.B.
Berg, W.B. van den

January 2006

Contains fulltext : 49248.pdf (publisher's version ) (Closed access)Rheumatoid art...

IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis?

Lubberts, Erik

February 2008

textabstractInterleukin-17A (IL-17A) contributes to the pathogenesis of arthritis. Data from experim...

The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models.

Lubberts, E.
Koenders, M.I.
Berg, W.B. van den

January 2005

Contains fulltext : 48096.pdf (publisher's version ) (Open Access)Interleukin-17 (...

Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.

Koenders, M.I.
Lubberts, E.
Oppers-Walgreen, B.
Bersselaar, L.A.M. van den
Helsen, M.M.A.
Padova, F.E. Di
Boots, A.M.H.
Gram, H.
Joosten, L.A.B.
Berg, W.B. van den

January 2005

Contains fulltext : 47662.pdf (publisher's version ) (Closed access)Rheumatoid art...

Neutrophils are essential as a source of IL-17 in the effector phase of arthritis. PLoS One. 2013; 8:e62231. [PubMed: 23671588

Masaki Katayama
Koichiro Ohmura
Naoichiro Yukawa
Chikashi Terao
Motomu Hashimoto
Hajime Yoshifuji
Daisuke Kawabata
Takao Fujii
Yoichiro Iwakura
Tsuneyo Mimori

August 2016

Objective: Th17 has been shown to have a pivotal role in the development of arthritis. However, the ...

Incomplete response of inflammatory arthritis to TNF alpha blockade is associated with the Th17 pathway

Alzabin, S
Abraham, SM
Taher, TE
Palfreeman, A
Hull, D
McNamee, K
Jawad, A
Pathan, E
Kinderlerer, A
Taylor, PC
Williams, R
Mageed, R

October 2012

Objectives: To establish if changes in Th1/Th17 cell populations previously reported in experimental...

Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway.

Alzabin, S
Abraham, SM
Taher, TE
Palfreeman, A
Hull, D
McNamee, K
Jawad, A
Pathan, E
Kinderlerer, A
Taylor, PC
Williams, R
Mageed, R

October 2012

OBJECTIVES: To establish if changes in Th1/Th17 cell populations previously reported in experimental...

Higher efficacy of anti-IL-6/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis

Roeleveld, D.M.
Marijnissen, R.J.
Walgreen, B.
Helsen, M.M.A.
Bersselaar, L.A.M. van den
Loo, F.A. van de
Lent, P.L.E.M. van
Kraan, P.M. van der
Berg, W.B. van den
Koenders, M.I.

January 2017

Contains fulltext : 173198.pdf (publisher's version ) (Open Access)Th17 cells and ...

Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression.

Toh, M.L.
Gonzales, G.
Koenders, M.I.
Tournadre, A.
Boyle, D.
Lubberts, E.
Zhou, Y.
Firestein, G.S.
Berg, W.B. van den
Miossec, P.

January 2010

Contains fulltext : 89354.pdf (publisher's version ) (Open Access)BACKGROUND: The ...

Neutrophils are essential as a source of IL-17 in the effector phase of arthritis.

Masaki Katayama
Koichiro Ohmura
Naoichiro Yukawa
Chikashi Terao
Motomu Hashimoto
Hajime Yoshifuji
Daisuke Kawabata
Takao Fujii
Yoichiro Iwakura
Tsuneyo Mimori

OBJECTIVE: Th17 has been shown to have a pivotal role in the development of arthritis. However, the ...

Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.

Koenders, M.I.
Lubberts, E.
Oppers-Walgreen, B.
Bersselaar, L.A.M. van den
Helsen, M.M.A.
Kolls, J.
Joosten, L.A.B.
Berg, W.B. van den

January 2005

Contains fulltext : 48047.pdf (publisher's version ) (Closed access)OBJECTIVE: To ...

IL-17 as a future therapeutic target for rheumatoid arthritis.

Berg, W.B. van den
Miossec, P.

January 2009

Item does not contain fulltextThe discovery of interleukin (IL)-17 and its major cell source, the ty...

Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.

Grevers, L.C.
Lent, P.L.E.M. van
Koenders, M.I.
Walgreen, B.
Sloetjes, A.W.
Nimmerjahn, F.
Verbeek, J.S.
Berg, W.B. van den

January 2009

Contains fulltext : 80444.pdf (publisher's version ) (Closed access)OBJECTIVE: Pre...

Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice.

Koenders, M.I.
Devesa, I.
Marijnissen, R.J.
Abdollahi-Roodsaz, S.
Boots, A.M.H.
Walgreen, B.
Padova, F.E. Di
Nicklin, M.J.
Joosten, L.A.B.
Berg, W.B. van den

January 2008

Contains fulltext : 69671.pdf (publisher's version ) (Closed access)OBJECTIVE: Int...

T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.

Joosten, L.A.B.
Abdollahi-Roodsaz, S.
Heuvelmans-Jacobs, M.
Helsen, M.M.A.
Bersselaar, L.A.M. van den
Oppers-Walgreen, B.
Koenders, M.I.
Berg, W.B. van den

January 2008

Contains fulltext : 70898.pdf (publisher's version ) (Closed access)OBJECTIVE: The...

The TH17 pathway as a therapeutic target in experimental arthritis. Interfering with the induction and effector phases: not a problem et al.

Abstract

Extracted data

The TH17 pathway as a therapeutic target in experimental arthritis. Interfering with the induction and effector phases: not a problem et al.

Abstract

Extracted data

Related items

Related items